Cite
Alpha-1 Antitrypsin PI M Heterozygotes with Rare Variants: Do They Need a Clinical and Functional Follow-Up?
MLA
Annunziata, Anna, et al. “Alpha-1 Antitrypsin PI M Heterozygotes with Rare Variants: Do They Need a Clinical and Functional Follow-Up?” Journal of Clinical Medicine, vol. 13, no. 4, Feb. 2024, p. 1084. EBSCOhost, https://doi.org/10.3390/jcm13041084.
APA
Annunziata, A., Fiorentino, G., Balestrino, M., Rega, R., Spinelli, S., Atripaldi, L., Sola, A., Massaro, F., & Calabrese, C. (2024). Alpha-1 Antitrypsin PI M Heterozygotes with Rare Variants: Do They Need a Clinical and Functional Follow-Up? Journal of Clinical Medicine, 13(4), 1084. https://doi.org/10.3390/jcm13041084
Chicago
Annunziata, Anna, Giuseppe Fiorentino, Marco Balestrino, Roberto Rega, Sara Spinelli, Lidia Atripaldi, Alessio Sola, Federica Massaro, and Cecilia Calabrese. 2024. “Alpha-1 Antitrypsin PI M Heterozygotes with Rare Variants: Do They Need a Clinical and Functional Follow-Up?” Journal of Clinical Medicine 13 (4): 1084. doi:10.3390/jcm13041084.